General Information of Drug Off-Target (DOT) (ID: OT68V64E)

DOT Name Potassium channel subfamily K member 5 (KCNK5)
Synonyms Acid-sensitive potassium channel protein TASK-2; TWIK-related acid-sensitive K(+) channel 2
Gene Name KCNK5
Related Disease
Nephropathy ( )
Autoimmune disease ( )
Breast cancer ( )
Breast carcinoma ( )
Central hypoventilation syndrome, congenital ( )
Coronary heart disease ( )
Epilepsy ( )
Multiple sclerosis ( )
Primary aldosteronism ( )
Status epilepticus seizure ( )
Migraine disorder ( )
Psychotic disorder ( )
Schizophrenia ( )
UniProt ID
KCNK5_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF07885
Sequence
MVDRGPLLTSAIIFYLAIGAAIFEVLEEPHWKEAKKNYYTQKLHLLKEFPCLGQEGLDKI
LEVVSDAAGQGVAITGNQTFNNWNWPNAMIFAATVITTIGYGNVAPKTPAGRLFCVFYGL
FGVPLCLTWISALGKFFGGRAKRLGQFLTKRGVSLRKAQITCTVIFIVWGVLVHLVIPPF
VFMVTEGWNYIEGLYYSFITISTIGFGDFVAGVNPSANYHALYRYFVELWIYLGLAWLSL
FVNWKVSMFVEVHKAIKKRRRRRKESFESSPHSRKALQVKGSTASKDVNIFSFLSKKEET
YNDLIKQIGKKAMKTSGGGETGPGPGLGPQGGGLPALPPSLVPLVVYSKNRVPTLEEVSQ
TLRSKGHVSRSPDEEAVARAPEDSSPAPEVFMNQLDRISEECEPWDAQDYHPLIFQDASI
TFVNTEAGLSDEETSKSSLEDNLAGEESPQQGAEAKAPLNMGEFPSSSESTFTSTESELS
VPYEQLMNEYNKANSPKGT
Function pH-dependent, outwardly rectifying potassium channel. Outward rectification is lost at high external K(+) concentrations.
Tissue Specificity
Abundant expression in kidney, also detected in liver, placenta and small intestine. In the kidney, expression is restricted to the distal tubules and collecting ducts . Not expressed in proximal tubules or glomeruli .
KEGG Pathway
Taste transduction (hsa04742 )
Protein digestion and absorption (hsa04974 )
Reactome Pathway
Phase 4 - resting membrane potential (R-HSA-5576886 )

Molecular Interaction Atlas (MIA) of This DOT

13 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Nephropathy DISXWP4P Definitive Genetic Variation [1]
Autoimmune disease DISORMTM Strong Biomarker [2]
Breast cancer DIS7DPX1 Strong Biomarker [3]
Breast carcinoma DIS2UE88 Strong Biomarker [3]
Central hypoventilation syndrome, congenital DISQRK53 Strong Genetic Variation [4]
Coronary heart disease DIS5OIP1 Strong Genetic Variation [5]
Epilepsy DISBB28L Strong Biomarker [6]
Multiple sclerosis DISB2WZI Strong Biomarker [7]
Primary aldosteronism DISOEFNH Strong Genetic Variation [8]
Status epilepticus seizure DISY3BIC Strong Biomarker [9]
Migraine disorder DISFCQTG Limited Genetic Variation [10]
Psychotic disorder DIS4UQOT Limited Biomarker [11]
Schizophrenia DISSRV2N Limited Biomarker [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Potassium channel subfamily K member 5 (KCNK5). [12]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Potassium channel subfamily K member 5 (KCNK5). [13]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Potassium channel subfamily K member 5 (KCNK5). [14]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Potassium channel subfamily K member 5 (KCNK5). [15]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Potassium channel subfamily K member 5 (KCNK5). [16]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Potassium channel subfamily K member 5 (KCNK5). [18]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Potassium channel subfamily K member 5 (KCNK5). [18]
Triclosan DMZUR4N Approved Triclosan increases the expression of Potassium channel subfamily K member 5 (KCNK5). [19]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Potassium channel subfamily K member 5 (KCNK5). [21]
Coumestrol DM40TBU Investigative Coumestrol increases the expression of Potassium channel subfamily K member 5 (KCNK5). [22]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Potassium channel subfamily K member 5 (KCNK5). [17]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Potassium channel subfamily K member 5 (KCNK5). [20]
------------------------------------------------------------------------------------

References

1 Dominant-Negative Effect of a Missense Variant in the TASK-2 (KCNK5) K+ Channel Associated with Balkan Endemic Nephropathy.PLoS One. 2016 May 26;11(5):e0156456. doi: 10.1371/journal.pone.0156456. eCollection 2016.
2 Upregulation of K2P5.1 potassium channels in multiple sclerosis.Ann Neurol. 2010 Jul;68(1):58-69. doi: 10.1002/ana.22010.
3 The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.Mol Endocrinol. 2011 Aug;25(8):1326-36. doi: 10.1210/me.2011-0045. Epub 2011 Jun 16.
4 Task2 potassium channels set central respiratory CO2 and O2 sensitivity.Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2325-30. doi: 10.1073/pnas.0910059107. Epub 2010 Jan 19.
5 Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.Circ Res. 2018 Feb 2;122(3):433-443. doi: 10.1161/CIRCRESAHA.117.312086. Epub 2017 Dec 6.
6 Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-A TASK2 report of the AES/ILAE Translational Task Force of the ILAE.Epilepsia. 2017 Nov;58 Suppl 4:68-77. doi: 10.1111/epi.13908.
7 14-3-3 Proteins regulate K(2P) 5.1 surface expression on T lymphocytes.Traffic. 2017 Jan;18(1):29-43. doi: 10.1111/tra.12455. Epub 2016 Nov 27.
8 Mutations of the Twik-Related Acid-Sensitive K+ Channel 2 Promoter in Human Primary Aldosteronism.Endocrinology. 2018 Mar 1;159(3):1352-1359. doi: 10.1210/en.2017-03119.
9 Upregulated TWIK-related acid-sensitive K+ channel-2 in neurons and perivascular astrocytes in the hippocampus of experimental temporal lobe epilepsy.Epilepsia. 2009 Apr;50(4):654-63. doi: 10.1111/j.1528-1167.2008.01957.x. Epub 2009 Feb 12.
10 Detection and interpretation of shared genetic influences on 42 human traits.Nat Genet. 2016 Jul;48(7):709-17. doi: 10.1038/ng.3570. Epub 2016 May 16.
11 Fronto-parietal hypo-activation during working memory independent of structural abnormalities: conjoint fMRI and sMRI analyses in adolescent offspring of schizophrenia patients.Neuroimage. 2011 Sep 1;58(1):234-41. doi: 10.1016/j.neuroimage.2011.06.033. Epub 2011 Jun 29.
12 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
13 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
14 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
15 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
16 Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor alpha signalling and results in tamoxifen insensitive proliferation. BMC Cancer. 2014 Apr 23;14:283.
17 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
18 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
19 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
20 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
21 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
22 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.